Dietary Lutein and the Retinopathy of Prematurity - NCT00672230-97239 (Clinical Trial 218835)


Welcome To Clinical Connection



Our clinical trials database is updated daily
Over 250,000 individuals are currently being connected to clinical trials by ClinicalConnection.com!


Trials Alerts	Trials Search
Health Forum	Health News
RSS	Intro
Clinics & Sponsors	Member Login

View Clinical Trial (Medical Research Study)

Dietary Lutein and the Retinopathy of Prematurity - NCT00672230-97239 (Clinical Trial 218835)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy218835.aspx

** Please review additional "Nearby Studies" on right ----->

City:

Portland

State:

Zip Code:

97239

Conditions:

Lactation

Purpose:

The clinical trial aspect of this study is the provision of a lutein supplement to lactating women and compare the amount of lutein in the milk and blood with lactating women who do not receive the lutein supplement.

Study summary:

About one-fourth of preterm infants who weight less than 2 3/4 pounds at birth develop an eye problem. This problem occurs in the retina (back of the eye) and may result in blindness. This eye problem is called the retinopathy of prematurity(ROP). There are two yellow pigments in the retina called lutein and zeaxanthin. These pigments may protect the retina from being damaged by light. They may also protect the retina from being damaged by oxygen. These pigments are transferred from the mother to the baby. Most of this takes place during the last trimester of pregnancy. The situation could be worse if the baby receives formula. Most baby formulas do not contain lutein and zeaxanthin; breast milk does. Another worry is that breast milk may not have enough lutein and zeaxanthin if the mother does not eat enough vegetables and fruits. The purpose of this study is to measure the transfer of lutein and zeaxanthin from the mother to the baby, to measure the amount of lutein and zeaxanthin in breast milk, to find out if taking a lutein supplement will increase the amount of lutein in breast milk and to find out if dietary lutein and zeaxanthin are involved in the development of the retinopathy of prematurity (ROP).

Criteria:

Inclusion Criteria: - Planning to breast feed for at least 12 weeks - Willing to be randomized to take the lutein supplement Exclusion Criteria: - Insufficient quantity of breast milk

Study is available at:

Oregon Health and Science University
Portland, OR 97239
United States

Primary Contact:
Sonja L Connor, MS
Email: connors@ohsu.edu
Phone: 503-494-7775

Secondary Contact:
Sonja L Connor, MS
Email: connors@ohsu.edu
Phone: 503-494-7775

If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.

Trials Alerts:

If you would like to be notified of new clinical trials as they become available please register for a free account.

Data Source:		ClinicalTrials.gov
Date Processed:		March 15, 2010
Modifications to this listing:		Only selected fields are shown, please use the link above to view all information about this clinical trial.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.


Featured Nearby Studies:

Within 25 Miles

Osteoporosis in Females Over 65 Not Taking Hormone Therapy - Portland OR

Alzheimer's Disease - Portland OR

Alzheimer's with Agitation and Aggression - Portland OR

Depression - Portland OR

Treatment Resistant Depression - Portland OR

Within 50 Miles

Within 100 Miles


Clinical Trials Search

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.